Advanced Medical Technology Association Applauds N.J. Appellate Division for Reversing Trial Court Order Regarding FDA Evidence Admissibility
March 04, 2021
March 04, 2021
WASHINGTON, March 4 -- The Advanced Medical Technology Association issued the following statement on March 2, 2021:
* * *
The Advanced Medical Technology Association (AdvaMed) issued the following statement from Pat Fogarty, Vice President, Assistant General Counsel, and Director, Civil Justice Policy regarding today's decision from the New Jersey Appellate Division's decision to remand the McGinnis case for a new trial preceded by Rule 104 hearing on the 510(k) clearan . . .
* * *
The Advanced Medical Technology Association (AdvaMed) issued the following statement from Pat Fogarty, Vice President, Assistant General Counsel, and Director, Civil Justice Policy regarding today's decision from the New Jersey Appellate Division's decision to remand the McGinnis case for a new trial preceded by Rule 104 hearing on the 510(k) clearan . . .